| Literature DB >> 35578199 |
Sandra Pol-Castañeda1,2, Alba Carrero-Planells3,4, Cristina Moreno-Mulet1,2.
Abstract
BACKGROUND: Medication administration errors are among the most important adverse events in healthcare systems. To minimise the risk of this occurring, nursing training programmes should emphasise the overriding priority of patient safety. In this respect, simulation can be a valuable resource in teaching procedures, for patient safety in general and safe medication administration in particular. In this study, we evaluate the use of a simulation-based activity for students to acquire skills in safe medication administration, and consider the students' perceptions of this activity.Entities:
Keywords: Medication administration; Medication therapy management; Mix-methods; Nursing education; Patient safety; Simulation
Year: 2022 PMID: 35578199 PMCID: PMC9112449 DOI: 10.1186/s12912-022-00897-z
Source DB: PubMed Journal: BMC Nurs ISSN: 1472-6955
Clinical scenarios for the SBA
| Medication regimen | 500 ml PS + 30 mEq KCl every 12 h, IV (continuous infusion) | Ceftazidime 100 mg / kg / day. Distribute in 3 administration, every 8 h | Human albumin 6 g per litre of ascitic fluid obtained (intermittent infusion). Dilute in 250 ml of physiological serum and administer for 40 min |
| Drug presentation | 10 ml ampoule of 2 M KCl | 2 g vial of ceftazidime powder | 50 ml vial of 20% human albumin |
| Intervention | Calculate the quantity (ml) of KCl to be added to 500 ml of PS Calculate how many ampoules of KCl are needed Calculate the infusion rate of the medication (ml/h) | Calculate the quantity (g) of ceftazidime to be diluted in 250 ml of PS Calculate how many vials of ceftazidime are needed for each infusion Calculate the infusion rate of the medication (ml/h) | Calculate the quantity (ml) of human albumin to be administered Calculate how many vials of human albumin are needed Calculate the infusion rate (ml/h) |
Abbreviations: KCl Potassium chloride, PS Physiological serum
Evaluation of Pre-S questionnaire and SBA
| Before medication administration | Which of the following drugs poses a serious risk if administered to patient A? ( | Check for allergies, susceptibilities, risks, health status, diagnosis according to nurses and doctors, expected results, possible adverse effects Before administration, prepare medication and perform proper hand washing. |
| Right patient | How would you identify the patient? ( | At least, check the patient's name against the ID bracelet. ( |
| Right medication | Which of the following drugs cannot be administered to the patient A? ( Just before preparing the drug dilution (morphic chloride), what actions should you take to verify that the drug presentation is safe? ( | Select the drug to be administered from different drugs and presentations. ( |
| Right dose | Patient B is prescribed 5 mg of morphic chloride (1 ml 2% ampoules). How many ml of the morphine ampoule are needed? | Correctly calculate the dose to be administered ( |
| Right route | The morphine that you have just prepared should not be administered by which of these routes? ( | Select appropriate material for drug administration and simulate administration by the appropriate route. ( |
| Right time | An unforeseen event occurs and you must leave the room. Which of the drugs that you must administer to patient A and/or patient B can be delayed for 30 min? ( | Explicitly show that the time at which the medication must be administered has been checked ( |
| Right documentation | Regarding the administration of morphine to patient B, what relevant information should you record in the medical history? ( | On concluding drug administration, record this fact, including the dose and any incident occurring during the administration. ( |
| After medication administration | - | Monitor the treatment effects, side effects and possible interactions. ( |
Respondents’ characteristics
| Male | 8 | 11% |
| Female | 65 | 89% |
| 18–25 | 44 | 60.3% |
| 26–39 | 12 | 16.4% |
| > 40 | 9 | 12.3% |
| Not recorded | 8 | 11% |
| Yes | 22 | 30.2% |
| No | 43 | 58.9% |
| Not recorded | 8 | 10.9% |
| Yes | 10 | 13.7% |
| No | 56 | 76.7% |
| Not recorded | 7 | 9.6% |
Fig. 1Results obtained in the Pre-S questionnaire and the SBA